Treating Rett Syndrome and Related Spectrum Disorders
Rett syndrome is a unique postnatal neurological disorder that is first recognized in infancy. It almost always occurs in girls but in rare cases, can be seen in boys. It is most often misdiagnosed as autism, cerebral palsy, or non-specific developmental delay.
Rett syndrome is caused by mutations on the X chromosome on a gene called MECP2. There are more than 200 different mutations found on the MECP2 gene. Most of these mutations are found in eight different “hot spots.” Rett syndrome strikes all racial and ethnic groups, and occurs worldwide in 1 of every 10,000 female births. It is not a degenerative disorder.
We provide evaluation and treatment for all variations of Rett syndrome and related spectrum disorders, including:
- Typical and Atypical Rett syndrome
- Rett-related disorders
- MECP2-related disorders
- Males with MECP2 variants/Male Rett spectrum disorders
- CDKL5 developmental and epileptic encephalopathy (CDKL5DEE)/CDKL5 Deficiency Disorder
- FOXG1 Syndrome
- MECP2 Duplication Syndrome
